Price T Rowe Associates Inc Vir Biotechnology, Inc. Transaction History

Price T Rowe Associates Inc

$816 Billion
Q1 2024

A detailed history of Price T Rowe Associates Inc transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 53,379 shares of VIR stock, worth $472,404. This represents 0.0% of its overall portfolio holdings.

Number of Shares

53,379

Previous 86,604 38.36%

Holding current value

$472,404

Previous $872,000 37.96%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$8.6 - $11.9 $285,735 - $395,377	-33,225 Reduced 38.36%	53,379 $541,000
Q4 2023 Feb 14, 2024	SELL	$7.76 - $10.29 $1.16 Million - $1.54 Million	-149,323 Reduced 63.29%	86,604 $872,000
Q3 2023 Nov 14, 2023	SELL	$9.14 - $24.62 $5.17 Million - $13.9 Million	-566,107 Reduced 70.58%	235,927 $2.21 Million
Q2 2023 Aug 14, 2023	BUY	$23.2 - $27.29 $9.63 Million - $11.3 Million	415,089 Added 107.27%	802,034 $19.7 Million
Q1 2023 May 15, 2023	BUY	$22.26 - $30.85 $28,871 - $40,012	1,297 Added 0.34%	386,945 $9.01 Million

Q4 2022 Feb 14, 2023	BUY	$19.96 - $28.22 $778 - $1,100	39 Added 0.01%	385,648 $9.76 Million
Q3 2022 Nov 14, 2022	BUY	$18.26 - $31.1 $3.82 Million - $6.5 Million	209,070 Added 118.43%	385,609 $7.44 Million
Q2 2022 Aug 15, 2022	SELL	$19.08 - $26.7 $5.22 Million - $7.31 Million	-273,824 Reduced 60.8%	176,539 $4.5 Million
Q1 2022 May 16, 2022	SELL	$21.19 - $40.01 $3.12 Million - $5.88 Million	-147,070 Reduced 24.62%	450,363 $11.6 Million
Q4 2021 Feb 14, 2022	BUY	$30.97 - $54.03 $17.4 Million - $30.3 Million	560,914 Added 1535.95%	597,433 $25 Million
Q3 2021 Nov 15, 2021	SELL	$34.9 - $54.54 $1.37 Million - $2.15 Million	-39,334 Reduced 51.86%	36,519 $1.59 Million
Q2 2021 Aug 16, 2021	BUY	$38.75 - $51.0 $537,617 - $707,574	13,874 Added 22.39%	75,853 $3.59 Million
Q1 2021 May 17, 2021	SELL	$26.34 - $83.07 $90,530 - $285,511	-3,437 Reduced 5.25%	61,979 $3.18 Million
Q4 2020 Feb 16, 2021	BUY	$25.51 - $43.38 $1.67 Million - $2.84 Million	65,416 New	65,416 $1.75 Million

Others Institutions Holding VIR

# of Institutions

225

Shares Held

88.2M

Call Options Held

177K

Put Options Held

182K

View Full List

About Vir Biotechnology, Inc.

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $1.17B
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

More about VIR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Vir Biotechnology, Inc. Transaction History